Peralta, Flora A.
HRN: 28-90-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/21/2026
06/27/2026
IV
2.25g
Q8h
Necrotic Sacral Ulcer
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines